REBEKAH SCANLON GIZZI: Open Payments
NPI 1548035629 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 35 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $264 |
| Novo Nordisk Inc | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Exact Sciences Corporation | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Antares Pharma, Inc. | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| Edwards Lifesciences Corporation | 1 | $23 |
Products named: REXULTI, AIRSUPRA, The Cologuard Plus Collection Kit, GEMTESA, Wegovy, XIFAXAN, XYOSTED, Ozempic.
Industry payments across MA — which companies pay providers there.
